SCHEMBL6154099

SCHEMBL6154099

O=C(O)c1cccc(-c2nnc(Nc3cccc(Br)c3)s2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.62
ROCK1 Q13464 3/20 0.62
HDAC6 Q9UBN7 1/20 0.51
CSNK2A1 P68400 6/20 0.51
CSNK2A2 P19784 3/20 0.51
CSNK2B P67870 2/20 0.51
CSNK2A3 Q8NEV1 1/20 0.51
HDAC1 Q13547 3/20 0.48
HDAC2 Q92769 1/20 0.48
EPM2A O95278 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
PTPN9 P43378 1/20 0.47
DUSP3 P51452 1/20 0.47
PTPN11 Q06124 1/20 0.47
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154268 0.82 HSD17B1 (0.58) ROCK2ROCK1HDAC6HDAC1HDAC2
SCHEMBL370983 0.82 NPC1 (0.58) ROCK2ROCK1HDAC6CSNK2A1CSNK2A2
SCHEMBL6153975 0.77 ROCK2 (0.62) ROCK2ROCK1CSNK2A1RAB9AMEN1
SCHEMBL18038303 0.77 ROCK1 (1.00) ROCK2ROCK1
SCHEMBL6153968 0.77 KDM4E (0.52) ROCK1KDM4ENPC1RAB9AMEN1
SCHEMBL5556608 0.74 ROCK2 (0.50) ROCK2ROCK1KDM4ENPC1RAB9A
SCHEMBL6154281 0.74 NOTUM (0.57) ROCK2ROCK1HDAC6HDAC1HDAC2
SCHEMBL23220346 0.74 NPC1 (0.67) ROCK2ROCK1HDAC6HDAC1KDM4E
SCHEMBL6153927 0.74 ALDH1A1 (0.52) ROCK2ROCK1HDAC6HDAC1HDAC2
SCHEMBL6153810 0.74 KMO (0.55) ROCK2ROCK1HDAC6HDAC1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP ROCK2 3224/4885ROCK1 3290/4885HDAC6 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.